Bringing the fundamentals into focus…
Back to BioCryst Pharmaceuticals, Inc.
How BioCryst Pharmaceuticals, Inc. stacks up
BCRX · against 356 other Healthcare companies of similar size
Growth
89/ 100
Near the top of its peers.
Ranked #44 of 357 · scores higher than 87% of peers
Bars: peers in each 10-point band of the growth score42 peers with a growth score of 80–89, including BCRX · Click a bar to see the companies
Why growth scores 89?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 92% of peers. 3-year revenue growth: 45.3% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 92% of peers. Revenue growth: 68.7% vs peer median 6.1%
Metric by metric
Position: dot = BCRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | BCRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 357 reported | 68.7% | 6.8% | 93% | 33% | |
| Earnings per share growthHigher is better · 206 reported | Not reported | 9.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 349 reported | 45.3% | 8.3% | 91% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around BCRX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 44 | 18.7B CNY (≈$2.6B) | 89 | 51 | |
| 44 | 2.4B EUR (≈$2.6B) | 89 | 69 | |
| 44 | 1.7B USD | 89 | 77 | |
| 44 | 1.8B USD | 89 | 52 | |
| 44 | 2.2B USD | 89 | 32 | |
| 49 | 2.4B SGD (≈$1.8B) | 88 | 79 | |
| 49 | 4.3B USD | 88 | 69 | |
| 49 | 1.3B USD | 88 | 58 | |
| 52 | 1.9B USD | 87 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score